Introduction
It is hard to imagine a clinical pharmacologist today approaching the dose an antidote based on a strategy of the same dose for every case. Nevertheless, for paracetamol (acetaminophen) this approach has been successful has been used for almost 50 years, and there is little doubt has saved many lives. Is it now time to reassess this ‘one dose for all’ policy?